Bactenecin-7 (1-16)

General Information


DRACP ID  DRACP03487

Peptide Name   Bactenecin-7 (1-16)

Sequence  RRIRPRPPRLPRPRPR

Sequence Length  16

UniProt ID  P19661 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03487

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C90H162N40O17

Absent amino acids  ACDEFGHKMNQSTVWY

Common amino acids  R

Mass  234422

Pl  13.35

Basic residues  8

Acidic residues  0

Hydrophobic residues  2

Net charge  8

Boman Index  -10952

Hydrophobicity  -233.13

Aliphatic Index  48.75

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 34360723

Title  Effects of Lipidation on a Proline-Rich Antibacterial Peptide

Doi Not available

Year  2021

Literature 2

Pubmed ID 32787108

Title  Peptide Inhibitors of Bacterial Protein Synthesis with Broad Spectrum and SbmA-Independent Bactericidal Activity against Clinical Pathogens

Doi Not available

Year  2020

Literature 3

Pubmed ID 31209863

Title  Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery

Doi Not available

Year  2019

Literature 4

Pubmed ID 25525837

Title  Effect of size and N-terminal residue characteristics on bacterial cell penetration and antibacterial activity of the proline-rich peptide Bac7

Doi Not available

Year  2015

Literature 5

Pubmed ID 15572192

Title  Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates

Doi Not available

Year  2004

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  5248

DRACP is developed by Dr.Zheng's team.